ARCHIMEDES Compassionate Use Supplement

NO_LONGER_AVAILABLE

Conditions studied: Pain

In brief

The purpose of this Compassionate Use Supplement to the IDE Protocol is to assure and monitor the safety of six Subjects (in the United States) implanted with ARCHIMEDES until all remaining implanted pumps are explanted.

Key facts

Study ID

NCT00660556

Run by

Cerenovus, Part of DePuy Synthes Products, Inc.

Last updated by the study team

2020-11-06

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• U. S. Subjects implanted with constant flow pump in 2003.

You may not qualify if…

• N/A

Where it is running

• South Side Pain Solutions — Danville, Virginia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.